Amylyx Pharmaceuticals Share Price (NASDAQ: AMLX)

$9.31

▲

0.15

(1.64%)

Live

Last updated on August 28, 2025 at 12:44 am IST

$₹

Check the interactive Amylyx Pharmaceuticals Stock chart to analyse performance

Amylyx Pharmaceuticals stock performance

as on August 28, 2025 at 12:44 am IST

Today's Low:$9.04
Today's High:$9.36
$9.31
2.9%
Downside
Day's Volatility :3.42%
Upside
0.53%
52 Weeks Low:$2.05
52 Weeks High:$9.38
$9.31
78.03%
Downside
52 Weeks Volatility :78.19%
Upside
0.73%

Amylyx Pharmaceuticals Stock Returns

Period	Amylyx Pharmaceuticals, Inc.	Sector (Health Care)	Index (Russel 2000)
3 Months	91.02%	3.7%	0.0%
6 Months	185.94%	-6.9%	0.0%
1 Year	329.58%	-11.9%	0.0%
3 Years	-64.12%	7.7%	-6.9%

Amylyx Pharmaceuticals, Inc. Key Stats

Check Amylyx Pharmaceuticals key stats like market cap, P/E ratio, EPS, Dividend Yield, and more.

Previous Close	$9.16
Open	$8.515
Today's High	$9.5
Today's Low	$9.04
Market Capitalization	$829.3M
Today's Volume	$951.0K
52 Week High	$9.378
52 Week Low	$2.045
Revenue TTM	$-249.0K
EBITDA	$-196.3M
Earnings Per Share (EPS)	$-2.28
Profit Margin	0.0%
Quarterly Earnings Growth YOY	0.0%
Return On Equity TTM	-87.42%

Stock Returns calculator for Amylyx Pharmaceuticals Stock including INR - Dollar returns

The Amylyx Pharmaceuticals stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.

Investment Value

₹1,00,000

Amylyx Pharmaceuticals investment value today

Current value as on today

₹4,41,762

Returns

₹3,41,762

(+341.76%)

Returns from Amylyx Pharmaceuticals Stock

₹3,37,089 (+337.09%)

Dollar Returns*

₹4,673 (+4.67%)

Indian investors sentiment towards Amylyx Pharmaceuticals Stock

10%

Period: Jul 27, 2025 to Aug 26, 2025. Change in 30 Days versus previous period

Search interest for Amylyx Pharmaceuticals Stock from India on INDmoney has increased by 10% in the last 30 days, reflecting an upward trend in search activity.

Global Institutional Holdings in Amylyx Pharmaceuticals, Inc.

Name
Holdings %
Name
Holdings %
Perceptive Advisors LLC
8.86%
TCG Crossover Management, LLC
6.67%
Adage Capital Partners Gp LLC
6.39%
Point72 Asset Management, L.P.
5.09%
Vanguard Group Inc
5.04%
Millennium Management LLC
3.46%

Analyst Recommendation on Amylyx Pharmaceuticals Stock

Rating

Trend

Buy

53%Buy

46%Hold

0%Sell

Based on 13 Wall street analysts offering stock ratings for Amylyx Pharmaceuticals(by analysts ranked 0 to 5 stars)

Amylyx Pharmaceuticals Share Price Target

What analysts predicted

Upside of 24.87%

Target:

$11.63

Current:

$9.31

Amylyx Pharmaceuticals share price target is $11.63, a slight Upside of 24.87% compared to current price of $9.31 as per analysts' prediction.

Amylyx Pharmaceuticals Stock Insights

Price Movement
In the last 7 days, AMLX stock has moved up by 13.9%
Decreasing Revenue
Revenue is down for the last 2 quarters, 416.0K → -665.0K (in $), with an average decrease of 259.9% per quarter
Decreasing Net Profit
Netprofit is down for the last 2 quarters, -35.90M → -41.44M (in $), with an average decrease of 15.4% per quarter
AMLX vs ALNY (3 yr)
In the last 3 years, Alnylam Pharmaceuticals, Inc. has given 113.9% return, outperforming this stock by 179.1%

Amylyx Pharmaceuticals Technicals Summary

Sell

Neutral

Buy

Amylyx Pharmaceuticals is currently in a favorable trading position ( BUY ) according to technical analysis indicators.

Amylyx Pharmaceuticals, Inc. Vs Peers

Returns

Ratio's

Overview

Company Name	1 Month	6 Month	1 Year	3 Years	5 Years
Amylyx Pharmaceuticals, Inc.	14.52%	185.94%	329.58%	-64.12%	-49.36%
Regeneron Pharmaceuticals, Inc.	5.16%	-16.9%	-51.12%	-0.89%	-2.51%
Beone Medicines Ltd	4.54%	18.87%	52.28%	84.02%	26.72%
Vertex Pharmaceuticals Incorporated	-16.02%	-19.22%	-19.42%	37.43%	43.36%
Alnylam Pharmaceuticals, Inc.	38.9%	84.99%	60.96%	115.82%	243.29%

Company Name	P/E Ratio	P/B Ratio	PEG Ratio	EPS	ROE	ROA	Div Yield	BVPS
Amylyx Pharmaceuticals, Inc.	2.51	NA	NA	-1.83	-0.87	-0.47	NA	1.88
Regeneron Pharmaceuticals, Inc.	14.86	14.86	1.21	39.42	0.15	0.07	0.0	287.55
Beone Medicines Ltd	NA	NA	NA	2.29	-0.05	-0.01	NA	34.32
Vertex Pharmaceuticals Incorporated	27.64	27.64	0.58	18.06	0.23	0.13	NA	67.02
Alnylam Pharmaceuticals, Inc.	NA	NA	-0.49	3.92	-2.58	-0.03	NA	1.91

Company Name	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin
Amylyx Pharmaceuticals, Inc.	Buy	$829.3M	-49.36%	2.51	0.0%
Regeneron Pharmaceuticals, Inc.	Buy	$62.5B	-2.51%	14.86	31.37%
Beone Medicines Ltd	NA	$38.3B	26.72%	NA	-3.89%
Vertex Pharmaceuticals Incorporated	Buy	$99.7B	43.36%	27.64	31.86%
Alnylam Pharmaceuticals, Inc.	Buy	$58.2B	243.29%	NA	-12.96%

About Amylyx Pharmaceuticals, Inc.

Amylyx Pharmaceuticals, Inc., a clinical-stage pharmaceutical company, engages in the discovery and development of treatment options for neurodegenerative diseases and endocrine conditions in the United States. Its lead products candidate includes avexitide, an investigational, first-in-class glucagon-like peptide-1, or GLP-1 receptor antagonist, which is in phase 3 clinical trial to treat post-bariatric hypoglycemia and congenital hyperinsulinism. The company also develops AMX0035, an oral, fixed-dose combination of sodium phenylbutyrate and taurursodiol which is phase 2 clinical trial for the treatment of wolfram syndrome, as well as in phase 2b/3 clinical trial to treat progressive supranuclear palsy; AMX0114, which is in phase 1 clinical trial for the treatment of amyotrophic lateral sclerosis; and long-acting GLP-1 receptor antagonist to treat post-bariatric hypoglycemia and other rare diseases. Amylyx Pharmaceuticals, Inc. was founded in 2013 and is headquartered in Cambridge, Massachusetts.

Organization	Amylyx Pharmaceuticals
Employees	123
CEO	Mr. Justin B. Klee
Industry	Services

Key Management of Amylyx Pharmaceuticals, Inc.

Name	Title
Mr. Joshua B. Cohen	Co-Founder, Co-CEO & Director
Mr. Justin B. Klee	Co-Founder, Co-CEO & Director
Mr. James M. Frates M.B.A.	Chief Financial Officer
Ms. Gina M. Mazzariello J.D.	Chief Legal Officer & General Counsel
Mr. Tom Holmes	Chief Technical Operations Officer
Ms. Lindsey Allen	Head of Investor Relations & Communications
Ms. Linda A. Arsenault	Chief Human Resources Officer
Ms. Tammy Sarnelli	Global Head of Regulatory Affairs
Dr. Machelle Manuel Ph.D.	VP & Head of Global Medical Affairs
Dr. Jamie Timmons	Head of Global Medical Strategy & Communications

Important FAQs about investing in AMLX Stock from India :

What is Amylyx Pharmaceuticals share price today?

Amylyx Pharmaceuticals share price today is $9.31 as on August 28, 2025 at 12:44 am IST. Amylyx Pharmaceuticals share today touched a day high of $9.36 and a low of $9.04.

What is the 52 week high and 52 week low for Amylyx Pharmaceuticals share?

Amylyx Pharmaceuticals share touched a 52 week high of $9.38 and a 52 week low of $2.05. Amylyx Pharmaceuticals stock price today i.e. August 28, 2025 at 12:44 am IST is trending at $9.31, lower by 0.73% versus the 52 week high.

How to invest in Amylyx Pharmaceuticals Stock (AMLX) from India?

Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
Step 2: Search for Amylyx Pharmaceuticals on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Amylyx Pharmaceuticals Shares that will get you 0.1611 shares as per Amylyx Pharmaceuticals share price of $9.31 per share as on August 28, 2025 at 12:44 am IST.

What is the minimum amount required to buy Amylyx Pharmaceuticals Stock (AMLX) from India?

Indian investors can start investing in Amylyx Pharmaceuticals (AMLX) shares with as little as ₹87.86 or $1 (as of August 27, 2025) using the INDmoney app.
For example: If you want to invest $10 or ₹878.60 in Amylyx Pharmaceuticals stock (as per the Rupee-Dollar exchange rate as on August 27, 2025). Based on Amylyx Pharmaceuticals share’s latest price of $9.31 as on August 28, 2025 at 12:44 am IST, you will get 1.0741 shares of Amylyx Pharmaceuticals. Learn more about fractional shares .

What are the returns that Amylyx Pharmaceuticals has given to Indian investors in the last 5 years?

Amylyx Pharmaceuticals stock has given -49.36% share price returns and 18.89% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?